
### [MONDO:0019293](http://purl.obolibrary.org/obo/MONDO_0019293)
**Label:** skin vascular disease

**Subclasses:** [MONDO:0019557](http://purl.obolibrary.org/obo/MONDO_0019557) (Chilblain lupus), [MONDO:0017216](http://purl.obolibrary.org/obo/MONDO_0017216) (calciphylaxis cutis), [MONDO:0009055](http://purl.obolibrary.org/obo/MONDO_0009055) (cutis marmorata telangiectatica congenita (disease)), [MONDO:0010880](http://purl.obolibrary.org/obo/MONDO_0010880) (telangiectasia, hereditary hemorrhagic, type 2), [MONDO:0008840](http://purl.obolibrary.org/obo/MONDO_0008840) (ataxia telangiectasia), [MONDO:0008841](http://purl.obolibrary.org/obo/MONDO_0008841) (ataxia-telangiectasia with generalized skin pigmentation and early death), [MONDO:0008501](http://purl.obolibrary.org/obo/MONDO_0008501) (Sturge-Weber syndrome), [MONDO:0008842](http://purl.obolibrary.org/obo/MONDO_0008842) (ataxia with oculomotor apraxia type 1), [MONDO:0019180](http://purl.obolibrary.org/obo/MONDO_0019180) (hereditary hemorrhagic telangiectasia), [MONDO:0007864](http://purl.obolibrary.org/obo/MONDO_0007864) (Klippel-Trenaunay syndrome), [MONDO:0007203](http://purl.obolibrary.org/obo/MONDO_0007203) (blue rubber bleb nevus), [MONDO:0013739](http://purl.obolibrary.org/obo/MONDO_0013739) (Chilblain lupus 2), [MONDO:0011457](http://purl.obolibrary.org/obo/MONDO_0011457) (ataxia-telangiectasia-like disorder), [MONDO:0012500](http://purl.obolibrary.org/obo/MONDO_0012500) (Chilblain lupus 1), [MONDO:0010526](http://purl.obolibrary.org/obo/MONDO_0010526) (Fabry disease), [MONDO:0018827](http://purl.obolibrary.org/obo/MONDO_0018827) (familial Chilblain lupus), [MONDO:0008094](http://purl.obolibrary.org/obo/MONDO_0008094) (familial multiple nevi flammei), [MONDO:0011240](http://purl.obolibrary.org/obo/MONDO_0011240) (megalencephaly-capillary malformation-polymicrogyria syndrome), [MONDO:0014399](http://purl.obolibrary.org/obo/MONDO_0014399) (PCNA-related progressive neurodegenerative photosensitivy syndrome), [MONDO:0010391](http://purl.obolibrary.org/obo/MONDO_0010391) (angioma serpiginosum, X-linked), [MONDO:0019566](http://purl.obolibrary.org/obo/MONDO_0019566) (Klippel-TrC)naunay syndrome), [MONDO:0016311](http://purl.obolibrary.org/obo/MONDO_0016311) (Bockenheimer syndrome), [MONDO:0018893](http://purl.obolibrary.org/obo/MONDO_0018893) (Cobb syndrome), [MONDO:0018892](http://purl.obolibrary.org/obo/MONDO_0018892) (Wyburn-Mason syndrome), [MONDO:0017242](http://purl.obolibrary.org/obo/MONDO_0017242) (cutaneous collagenous vasculopathy), [MONDO:0008534](http://purl.obolibrary.org/obo/MONDO_0008534) (generalized essential telangiectasia), [MONDO:0008535](http://purl.obolibrary.org/obo/MONDO_0008535) (telangiectasia, hereditary hemorrhagic, of Rendu, Osler, and Weber), [MONDO:0007115](http://purl.obolibrary.org/obo/MONDO_0007115) (angioma serpiginosum, autosomal dominant), [MONDO:0013806](http://purl.obolibrary.org/obo/MONDO_0013806) (familial cutaneous telangiectasia and oropharyngeal predisposition cancer syndrome), [MONDO:0013808](http://purl.obolibrary.org/obo/MONDO_0013808) (Maffucci syndrome), [MONDO:0012017](http://purl.obolibrary.org/obo/MONDO_0012017) (Parkes Weber syndrome), [MONDO:0012532](http://purl.obolibrary.org/obo/MONDO_0012532) (HHT4), [MONDO:0011208](http://purl.obolibrary.org/obo/MONDO_0011208) (malignant atrophic papulosis), [MONDO:0019803](http://purl.obolibrary.org/obo/MONDO_0019803) (angioma serpiginosum), [MONDO:0010996](http://purl.obolibrary.org/obo/MONDO_0010996) (HHT3), [MONDO:0014217](http://purl.obolibrary.org/obo/MONDO_0014217) (telangiectasia, hereditary hemorrhagic, type 5), 

**Corr. equiv. classes:** [OMIM:106050](http://purl.obolibrary.org/obo/OMIM_106050), [OMIM:602248](http://purl.obolibrary.org/obo/OMIM_602248), [Orphanet:53719](http://www.orpha.net/ORDO/Orphanet_53719), [Orphanet:2346](http://www.orpha.net/ORDO/Orphanet_2346), [Orphanet:1059](http://www.orpha.net/ORDO/Orphanet_1059), [Orphanet:95429](http://www.orpha.net/ORDO/Orphanet_95429), [Orphanet:313846](http://www.orpha.net/ORDO/Orphanet_313846), [OMIM:208920](http://purl.obolibrary.org/obo/OMIM_208920), [Orphanet:679](http://www.orpha.net/ORDO/Orphanet_679), [Orphanet:481662](http://www.orpha.net/ORDO/Orphanet_481662), [OMIM:219250](http://purl.obolibrary.org/obo/OMIM_219250), [OMIM:112200](http://purl.obolibrary.org/obo/OMIM_112200), [OMIM:601101](http://purl.obolibrary.org/obo/OMIM_601101), [Orphanet:53721](http://www.orpha.net/ORDO/Orphanet_53721), [OMIM:187300](http://purl.obolibrary.org/obo/OMIM_187300), [OMIM:600376](http://purl.obolibrary.org/obo/OMIM_600376), [OMIM:187260](http://purl.obolibrary.org/obo/OMIM_187260), [OMIM:300652](http://purl.obolibrary.org/obo/OMIM_300652), [OMIM:301500](http://purl.obolibrary.org/obo/OMIM_301500), [OMIM:614564](http://purl.obolibrary.org/obo/OMIM_614564), [Orphanet:1168](http://www.orpha.net/ORDO/Orphanet_1168), [Orphanet:251347](http://www.orpha.net/ORDO/Orphanet_251347), [OMIM:208910](http://purl.obolibrary.org/obo/OMIM_208910), [OMIM:614569](http://purl.obolibrary.org/obo/OMIM_614569), [Orphanet:624](http://www.orpha.net/ORDO/Orphanet_624), [OMIM:610448](http://purl.obolibrary.org/obo/OMIM_610448), [Orphanet:100](http://www.orpha.net/ORDO/Orphanet_100), [OMIM:602501](http://purl.obolibrary.org/obo/OMIM_602501), [Orphanet:90280](http://www.orpha.net/ORDO/Orphanet_90280), [Orphanet:280774](http://www.orpha.net/ORDO/Orphanet_280774), [Orphanet:438134](http://www.orpha.net/ORDO/Orphanet_438134), [OMIM:149000](http://purl.obolibrary.org/obo/OMIM_149000), [OMIM:208900](http://purl.obolibrary.org/obo/OMIM_208900), [OMIM:614415](http://purl.obolibrary.org/obo/OMIM_614415), [Orphanet:163634](http://www.orpha.net/ORDO/Orphanet_163634), [OMIM:610655](http://purl.obolibrary.org/obo/OMIM_610655), [OMIM:615506](http://purl.obolibrary.org/obo/OMIM_615506), [Orphanet:774](http://www.orpha.net/ORDO/Orphanet_774), [Orphanet:1556](http://www.orpha.net/ORDO/Orphanet_1556), [OMIM:185300](http://purl.obolibrary.org/obo/OMIM_185300), [Orphanet:280065](http://www.orpha.net/ORDO/Orphanet_280065), [Orphanet:90308](http://www.orpha.net/ORDO/Orphanet_90308), [Orphanet:217008](http://www.orpha.net/ORDO/Orphanet_217008), [Orphanet:3205](http://www.orpha.net/ORDO/Orphanet_3205), [Orphanet:60040](http://www.orpha.net/ORDO/Orphanet_60040), [Orphanet:90307](http://www.orpha.net/ORDO/Orphanet_90307), [OMIM:163000](http://purl.obolibrary.org/obo/OMIM_163000), [Orphanet:280779](http://www.orpha.net/ORDO/Orphanet_280779), [OMIM:608355](http://purl.obolibrary.org/obo/OMIM_608355), [Orphanet:324](http://www.orpha.net/ORDO/Orphanet_324), [OMIM:604391](http://purl.obolibrary.org/obo/OMIM_604391), [OMIM:615919](http://purl.obolibrary.org/obo/OMIM_615919), 

**Class expressions from DL-Learner:**

- [HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology) and [HP:0100026](http://purl.obolibrary.org/obo/HP_0100026) (Arteriovenous malformation) 47.86%
- [HP:0001574](http://purl.obolibrary.org/obo/HP_0001574) (Abnormality of the integument) and [HP:0100026](http://purl.obolibrary.org/obo/HP_0100026) (Arteriovenous malformation) 47.86%
- [HP:0000951](http://purl.obolibrary.org/obo/HP_0000951) (Abnormality of the skin) and [HP:0100026](http://purl.obolibrary.org/obo/HP_0100026) (Arteriovenous malformation) 47.86%
- [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) and [HP:0100026](http://purl.obolibrary.org/obo/HP_0100026) (Arteriovenous malformation) 46.57%
- [HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system) and [HP:0100026](http://purl.obolibrary.org/obo/HP_0100026) (Arteriovenous malformation) 44.88%
- [HP:0100026](http://purl.obolibrary.org/obo/HP_0100026) (Arteriovenous malformation) 44.64%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 41.69%
- Thing 41.67%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 41.67%
- [HP:0001009](http://purl.obolibrary.org/obo/HP_0001009) (Telangiectasia) 39.90%
- [HP:0001574](http://purl.obolibrary.org/obo/HP_0001574) (Abnormality of the integument) 39.77%
- [HP:0001626](http://purl.obolibrary.org/obo/HP_0001626) (Abnormality of the cardiovascular system) 37.20%
- [HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system) 29.50%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) 29.49%
- [HP:0000478](http://purl.obolibrary.org/obo/HP_0000478) (Abnormality of the eye) 27.03%


